ProPSMA and TheraP ­– changing patient care - with Michael Hofman

Professor Michael Hofman has contributed to some of the most important progress for imaging and treatment of prostate cancer. And his collaborative approach has brought together multi-disciplinary expertise from more than 10 centers around Australia.

– If you have the energy to put together a clinical trial protocol I bet colleagues around your country will be happy to adopt it. It is a win-win for everyone.

Please join us in this episode of Theragnostic Talks.

Guest: Prof. Michael Hofman

By: Annette Andrén and Gustav Widar

Contact us: [email protected]

For more info, visit www.samnordic.se